VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TLRY
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
TLRYTilray Brands, Inc.
$4.31$502M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. TLRY
  4. Financial Ratios

Tilray Brands, Inc. (TLRY) Financial Ratios

Latest Ratios: P/E Ratio -0.1x · EV/EBITDA N/A · ROE -89.1%. (2012–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

TLRY Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$502M$38M$134M$103M$216M$449M$225M$773M———
Enterprise Value$649M$185M$350M$620M$478M$900M$721M$694M———
P/E Ratio →-0.13——————————
P/S Ratio0.450.030.120.120.270.730.554.31———
P/B Ratio0.190.020.030.020.040.100.592.87———
P/FCF———————————
P/OCF———9.69———————

P/E links to full P/E history page with 30-year chart

TLRY EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—0.160.330.730.601.451.783.87———
EV / EBITDA———————————
EV / EBIT———————————
EV / FCF———————————

TLRY Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin29.3%29.3%28.3%23.4%18.6%24.0%23.7%24.3%110.8%84.6%70.9%
Operating Margin-277.9%-277.9%-22.1%-218.4%-97.1%-25.8%-25.7%-77.5%-33.7%-6.8%-12.9%
Net Profit Margin-266.3%-266.3%-31.1%-231.6%-75.9%-71.6%-25.3%-14.0%79.8%20.5%4.7%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE-89.1%-89.1%-7.3%-38.8%-11.9%-18.3%-31.6%-19.0%—20.6%1.6%
ROA-68.1%-68.1%-5.6%-30.6%-9.3%-12.3%-9.8%-5.2%40.2%8.6%1.6%
ROIC-66.2%-66.2%-3.6%-25.5%-10.7%-4.1%-14.6%-84.7%-16.4%-3.4%-6.5%
ROCE-78.1%-78.1%-4.4%-31.1%-12.7%-4.8%-10.8%-32.2%-95.9%-4.9%-4.5%

TLRY Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity0.220.220.110.180.140.211.642.17—11.35—
Debt / EBITDA—————————94.98—
Net Debt / Equity—0.070.050.120.050.101.31-0.29—8.37-0.47
Net Debt / EBITDA—————————70.06—
Debt / FCF———————————
Interest Coverage-55.23-55.23-3.55-29.38-15.38-4.28-4.06-23.63-9.21-3.60—

TLRY Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio2.462.462.271.792.872.202.8021.370.250.5517.29
Quick Ratio1.491.491.421.321.991.561.8520.750.100.3615.64
Cash Ratio0.910.910.871.041.481.221.0519.960.050.3413.01
Asset Turnover—0.390.180.140.120.100.340.200.420.340.23
Inventory Turnover2.142.142.242.392.081.842.646.15-0.330.421.18
Days Sales Outstanding—53.9947.0550.1955.3462.0651.6348.4834.2613.75100.40

TLRY Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield———————————
Payout Ratio———————————

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield———————————
FCF Yield———————————
Buyback Yield0.0%0.0%0.0%1.6%0.0%0.0%3.0%0.0%———
Total Shareholder Yield0.0%0.0%0.0%1.6%0.0%0.0%3.0%0.0%———
Shares Outstanding—$89M$74M$62M$48M$27M$23M$20M$14M$9M$5M

Key Metrics

Growth RegimeDecelerating
ProfitabilityNegative
Balance SheetStrained
Cash FlowBurning
Top Statement Risk

Persistent Operating Margin Deficits

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Conglomerate Discount Masks Asset Value

Based on reported figures, Tilray's P/S ratio of 0.48 suggests the market is heavily discounting the company's diversified revenue streams, likely due to the persistent negative P/E of -0.14 and the ongoing uncertainty surrounding the integration of its disparate pharmaceutical and beverage business segments.

The current valuation appears to reflect a market skepticism toward the company's ability to achieve profitability, effectively pricing the stock as a distressed asset rather than a growth-oriented CPG entity. Investors should monitor whether the market continues to apply a conglomerate discount or if the beverage segment eventually warrants a standalone valuation multiple closer to traditional craft brewers.

Capital Efficiency Remains Fundamentally Impaired

As reported in recent financial statements, Tilray's ROIC has remained consistently negative, reaching -1.1% in 2026Q2, which indicates that the company is currently destroying shareholder value rather than compounding it through its aggressive horizontal expansion and capital-intensive infrastructure investments across multiple international jurisdictions.

The persistent inability to generate positive returns on invested capital suggests that the company's M&A-led growth strategy has failed to achieve the necessary scale to overcome its high fixed-cost base. This trend warrants further investigation into whether management can pivot toward organic efficiency or if the current asset base remains structurally incapable of delivering positive economic profit.

Working Capital Cycles Indicate Inefficiency

According to the latest quarterly data, Tilray's cash conversion cycle remains exceptionally high at 568 days in 2026Q2, a figure that highlights significant inefficiencies in managing inventory and receivables compared to broader industry standards for consumer packaged goods and pharmaceutical distribution entities.

The elevated days inventory outstanding, which reached 646 days in the most recent quarter, suggests a potential oversupply issue or a mismatch between production capacity and market demand. This inefficiency ties up critical liquidity and forces the company to rely on external financing, increasing the risk profile for shareholders during periods of market volatility.

Liquidity Buffer Faces Structural Pressure

Based on the company's reported figures, the current ratio of 2.81 provides a superficial appearance of liquidity, yet the quick ratio of 1.72, when adjusted for the high inventory levels, suggests that the company's ability to meet short-term obligations under stress remains vulnerable to persistent cash burn.

While the current ratio appears adequate, the reliance on inventory liquidation to satisfy short-term liabilities is a precarious position for a company operating in volatile regulatory environments. Investors should monitor the cash burn rate closely, as the current liquidity position may be insufficient to support long-term operations without further dilutive financing.

Misapplication of P/S Valuation Multiples

The P/S ratio is frequently misapplied to Tilray because it fails to account for the massive disparity in gross margins between the low-margin pharmaceutical distribution business and the higher-margin beverage alcohol segment, thereby obscuring the true quality of the company's consolidated revenue base.

Analysts should instead focus on a sum-of-the-parts valuation that separates the distribution business from the branded consumer segments to avoid overestimating the company's earning power. Relying on a consolidated P/S ratio ignores the structural drag of the distribution segment, which may lead to an inaccurate assessment of the company's long-term profitability potential.

Download Financial Ratios Data

Includes 30+ ratios · 12 years · Updated daily

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

TLRY — Frequently Asked Questions

Quick answers to the most common questions about buying TLRY stock.

What is Tilray Brands, Inc.'s P/E ratio?

Tilray Brands, Inc.'s current P/E ratio is -0.1x. This places it at the 50th percentile of its historical range.

What is Tilray Brands, Inc.'s ROE?

Tilray Brands, Inc.'s return on equity (ROE) is -89.1%. The historical average is -28.9%.

Is TLRY stock overvalued?

Based on historical data, Tilray Brands, Inc. is trading at a P/E of -0.1x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What are Tilray Brands, Inc.'s profit margins?

Tilray Brands, Inc. has 29.3% gross margin and -277.9% operating margin.